June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
The Purinergic 2 X Receptor Agonists ATP, BzATP and 2MeSATP use ER Stores to Increase Cytosolic Free Calcium
Author Affiliations & Notes
  • Haakon Fjaervoll
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    The Medical Student Research Program, Universitetet i Oslo Det medisinske fakultet, Oslo, Oslo, Norway
  • Ketil Fjaervoll
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    The Medical Student Research Program, Universitetet i Oslo Det medisinske fakultet, Oslo, Oslo, Norway
  • Menglu Yang
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Jeffrey Bair
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Tor Utheim
    Department of Medical Biochemistry, Oslo Universitetssykehus, Oslo, Norway
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Darlene A Dartt
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Haakon Fjaervoll None; Ketil Fjaervoll None; Menglu Yang None; Jeffrey Bair None; Tor Utheim None; Darlene Dartt None
  • Footnotes
    Support  NIH NEI EY019470, NFR 271555
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 1990 – A0320. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Haakon Fjaervoll, Ketil Fjaervoll, Menglu Yang, Jeffrey Bair, Tor Utheim, Darlene A Dartt; The Purinergic 2 X Receptor Agonists ATP, BzATP and 2MeSATP use ER Stores to Increase Cytosolic Free Calcium. Invest. Ophthalmol. Vis. Sci. 2022;63(7):1990 – A0320.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Ionotropic purinergic receptors (P2XRs) are formed as hetero- or homotrimers from seven subunits, and are activated by extracellular nucleotides such as ATP. Upon activation, the P2XRs become permeable to cations, leading to activation of intracellular signaling pathways and an increase in cytosolic free calcium ([Ca2+]i). All P2XRs are present on cultured rat conjunctival goblet cells (CGCs). The purpose of this study was to investigate the source of the free cytosolic calcium in CGCs after the stimulation with ATP and the ATP analogues BzATP and 2MeSATP.

Methods : Goblet cells were cultured from rat conjunctival explants. First passage CGCs were incubated with the ratiometric fluorescent dye Fura 2-AM in: 1. buffer containing calcium or in calcium free buffer with or without 2 mM EGTA, or 2. calcium-containing buffer with or without the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor thapsigargin (10-6 M) that depletes ER Ca2+ stores. The CGCs were then stimulated with the non-specific P2XR agonist ATP (10-7-10-5 M) or the ATP analogues BzATP (10-7-10-4 M) or 2MeSATP (10-7-10-5 M), and [Ca2+]i measured.

Results : [Ca2+]i was significantly increased from baseline when stimulated with ATP (10-7-10-4 M), BzATP (10-7-10-4 M) or 2MeSATP (10-7-10-5 M), with a maximal response for ATP at 10-5 M, BzATP at 10-4 M and 2MeSATP at 10-5 M in buffer containing calcium. The change in peak [Ca2+]i was not significantly different in calcium free buffer, but was significantly reduced in the presence of 2 mM EGTA. The [Ca2+]i increase in CGCs preincubated with thapsigargin was completely reduced for ATP at 10-4 M, BzATP at 10-4 M and 2MeSATP at 10-5 M.

Conclusions : We conclude that ATP and the ATP analogues BzATP and 2MeSATP increase [Ca2+]i mainly through releasing ER calcium stores.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×